Shyam Sundar

Revision as of 18:39, 6 January 2022 by ->Citation bot (Add: pmc, s2cid, pmid, authors 1-1. Removed proxy/dead URL that duplicated identifier. Removed parameters. Some additions/deletions were parameter name changes. | Use this bot. Report bugs. | Suggested by Headbomb | Linked from Wikipedia:WikiProject_Academic_Journals/Journals_cited_by_Wikipedia/Sandbox | #UCB_webform_linked 601/762)
(diff) ← Older revision | Latest revision (diff) | Newer revision → (diff)


Shyam Sundar is an Indian academic and professor at Banaras Hindu University. He works on Infectious Diseases - Leishmaniasis & HIV/AIDS.[1][2]

PublicationsEdit

  • Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?[3]
  • Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic[4]
  • Rapid accurate field diagnosis of Indian visceral leishmaniasis[5]
  • Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis[6]
  • Trial of oral miltefosine for visceral leishmaniasis[7]
  • Determinants of survival in adult HIV patients on antiretroviral therapy in Eastern Uttar Pradesh: A prospective study[8]

ReferencesEdit

  1. "Faculty List: Department of Medicine, IMS, BHU". www.bhu.ac.in. Retrieved 2021-02-13.
  2. "Explained: Why Stanford University has a list of the top 2 per cent scientists". The Indian Express. 2020-11-19. Retrieved 2021-02-13.
  3. Chappuis, François; Sundar, Shyam; Hailu, Asrat; Ghalib, Hashim; Rijal, Suman; Peeling, Rosanna W.; Alvar, Jorge; Boelaert, Marleen (November 2007). "Visceral leishmaniasis: what are the needs for diagnosis, treatment and control?". Nature Reviews Microbiology. 5 (11): 873–882. doi:10.1038/nrmicro1748. ISSN 1740-1534. PMID 17938629.
  4. Sundar, Shyam; More, Deepak K.; Singh, Manoj K.; Singh, Vijay P.; Sharma, Sashi; Makharia, Anand; Kumar, Prasanna C. K.; Murray, Henry W. (2000-10-01). "Failure of Pentavalent Antimony in Visceral Leishmaniasis in India: Report from the Center of the Indian Epidemic". Clinical Infectious Diseases. 31 (4): 1104–1107. doi:10.1086/318121. ISSN 1058-4838. PMID 11049798.
  5. Sundar, Shyam; Reed, Steven G; Singh, Vijay P; Kumar, Prasanna CK; Murray, Henry W (1998-02-21). "Rapid accurate field diagnosis of Indian visceral leishmaniasis". The Lancet. 351 (9102): 563–565. doi:10.1016/S0140-6736(97)04350-X. ISSN 0140-6736. PMID 9492776. S2CID 34982917.
  6. Nylén, Susanne; Maurya, Radheshyam; Eidsmo, Liv; Manandhar, Krishna Das; Sundar, Shyam; Sacks, David (2007-04-16). "Splenic accumulation of IL-10 mRNA in T cells distinct from CD4+CD25+ (Foxp3) regulatory T cells in human visceral leishmaniasis". Journal of Experimental Medicine. 204 (4): 805–817. doi:10.1084/jem.20061141. ISSN 0022-1007. PMC 2118563. PMID 17389235.
  7. Sundar, Shyam; Rosenkaimer, Frank; Makharia, Manoj K; Goyal, Ashish K; Mandal, Ashim K; Voss, Andreas; Hilgard, Peter; Murray, Henry W (1998-12-05). "Trial of oral miltefosine for visceral leishmaniasis". The Lancet. 352 (9143): 1821–1823. doi:10.1016/S0140-6736(98)04367-0. ISSN 0140-6736. PMID 9851383. S2CID 33761492.
  8. Chakravarty, Jaya; Tiwary, Narendra K.; Prasad, Shashi Ranjan; Shukla, Saurabh; Tiwari, Anurag; Mishra, Rabindra Nath; Sundar, Shyam (2014). "Determinants of survival in adult HIV patients on antiretroviral therapy in Eastern Uttar Pradesh: A prospective study". The Indian Journal of Medical Research. 140 (4): 491–500. ISSN 0971-5916. PMC 4277134. PMID 25488442.

External linksEdit